All lobbying filings

FERRING PHARMACEUTICALS, INC.

Lobbying for FERRING PHARMACEUTICALS, INC.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $160,000.00 expenses · posted Jul 18, 2025

Official filing document

Bills named in this filing 3

HCONRES 14
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appro…
HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
HR 1878
IVF Access and Affordability Act

Lobbying activity 2

Health Issues

Issues related to fertility treatment and coverage (no bill); issues related to federal employee health care coverage (no bill) issues related to veteran health care coverage (no bill); issues related to military health care coverage (no bill); issues related to Medicare physician fee schedule and Orphan Cures (To provide for reconciliation pursuant to title II of H. Con. Res. 14 (H.R. 1 / no Senate bill number)).

Taxation/Internal Revenue Code

Issues related to establishing a tax credit for fertility treatments (IVF Access and Affordability Act, H.R. 1878 / no Senate bill); issues related to taxation of foreign businesses (To provide for reconciliation pursuant to title II of H. Con. Res. 14 (H.R. 1 / no Senate bill number)).

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.